Date |
Information: |
2021 |
Janssen Medial Cloud: Nyresvikt som komplikasjon ved myelomatose av Fredrik Schjesvold
|
2021 |
Janssen Medial Cloud: Anemi som komplikasjon ved myelomatose av Fredrik Schjesvold |
05.02.2021 |
Fra Blodkreftforeningen: Webinar om myelomatose, i samarbeid med International Myeloma Foundation.
|
December 2020 |
OncologyTube.com: ASH2020: Multiple myeloma cancer research: 1411 isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma. ICARIA-MM subgroup analysis. |
10.12.2020 |
Dagens Medisin: DM Arena Digital Post American Society of Hematology (ASH) / hematologi 16:20-16:30: Siste nytt innen myelomatose, Fredrik Schjesvold
|
08.12.2020 |
Dagens Medisin – Det siste store er bispesifikke antistoffer |
08.12.2020 |
HealthTalk: Banebrytende CAR-T studie med T-celler fra friske donorer
|
08.12.2020 |
HealthTalk: Denne teknologien kan revolusjonere kreftbehandlingen
|
05.12.2020 |
HealthTalk: Myelomatose: Venetoclax + cobimetinib gir større respons enn venetoclax alene.
|
24.09.2020 |
Dagens Medisin: DM Arena Digital Post ESMO
|
19.09.2020 |
Dagens Medisin: Se debatten: – Hva er rettferdige priser på kreftmedisiner?
|
02.08.2020 |
NRK: Kreftpasienter får ikke tilgang til ny lovende medisin |
August 2020 |
Phillips Gilmore Oncology Communications: RRMM: How to Optimize Treatment Sequence |
22-23.06.2020 |
From Health Talk: Ny behandlingsmulighet for pasienter med AL amyloidose (YouTube clip) En ny standardbehandling for myelomatose?
|
21.06.2020 |
Fredrik Schjesvold interviewed about myeloma treatment on NRK Kveldsnytt (major national evening news programme , Norwegian Broadcasting Corporation): Link to the Kveldsnytt clip - Kreftbehandling |
25.05.2020 |
5 SPØRSMÅL OM MYELOMATOSE (BENMARGSKREFT) v/ Overlege Fredrik Schjesvold, Oslo Myelomatosesenter YouTube link - Link to video via Amgen home page |
Dec 2019 |
Dr Fredrik Schjesvold speaks to ecancer at the 2019 American Society of Hematology (ASH) meeting in Orlando (7-10 Dec 2019): KRd consolidation in MM patients with a positive PET-CT after standard first-line therapy: Results from the phase II CONPET trial |
15.11.19 |
The Norwegian "Blodkreftforeningen" (Leukemia Association) had a seminar on Myelomatosis in Oct/Nov 2019. Here is Fredrik Schjesvold's talk, in Norwegian (link to YouTube video): Myelomatose. Fredrik Schjesvold. Oslo myelomatosesenter; tilgang til ny behandling gjennom studier |
18.06.19 |
Video from MEDtalks from EHA 2019: EHA 2019: Ixazomib did not have an adverse impact on quality of life in newly diagnosed multiple myeloma Speaker: Fredrik Schjesvold From bestprac.no - published 18.06.19 - registering (free) required to get access. |
15.06.19 |
Video - Dr Evangelos Terpos, Prof Michele Cavo, Dr Eloísa Riva and Dr Fredrik Schjesvold discuss the deepening response seen with the use of ixazomib as a maintenance therapy following autologous stem cell transplantation Use of maintenance therapy following ASCT and real world treatment patterns in multiple myeloma From ecancertv.org - published 15.06.19 - registering (free) required to get access. |
May 2018 |
The 4th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy) May 3-5, 2018 Paris, France |
|
Video presentation of Oslo Myeloma Center |